Annual Drug Patent Expirations for DEXTENZA
Dextenza is a drug marketed by Ocular Therapeutix and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has twenty-five patent family members in six countries.
The generic ingredient in DEXTENZA is dexamethasone. One supplier is listed for this compound. Additional details are available on the dexamethasone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com